Alpelisib
Alpelisib | |
---|---|
Term | Alpelisib |
Short definition | Alpelisib (AL-peh-LIH-sib) A drug used with fulvestrant to treat postmenopausal women and men with hormone receptor-positive, HER2-negative breast cancer that is advanced or has spread and has a mutation (change) in the breast cancerPIK3CAGen. It is used in patients whose cancer has gotten worse during or after hormone therapy. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Alpelisib - (pronounced) (AL-peh-LIH-sib) A drug used with fulvestrant to treat postmenopausal women and men with hormone receptor-positive, HER2-negative breast cancer that is advanced or has spread and has a mutation (change) in the breast cancerPIK3CAGen. It is used in patients whose cancer has gotten worse during or after hormone therapy. It is also being studied in the treatment of other types of cancer. Alpelisib blocks certain proteins that can help stop cancer cells from growing and kill them. It's a kind of kinase inhibitor. Also called Piqray
External links
- Medical encyclopedia article on Alpelisib
- Wikipedia's article - Alpelisib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski